Founder & Board-Certified Family Nurse Practitioner
Last reviewed
Same Idea, Several Products on the Market
Botox, Dysport, Xeomin and Jeuveau are all FDA-approved forms of botulinum toxin type A — the same class of cosmetic injections, used the same way, to relax the muscles behind frown lines, forehead lines and crow's feet. None of them fill anything. All of them are temporary, wearing off over 3–4 months as the muscle regains normal activity.
The differences that actually matter are formulation, dosing units and how quickly each one becomes visible — not whether one 'works' and the others don't. At BUTEX we carry Botox, Dysport and Xeomin (along with Letybo), so this is a genuine comparison of options in front of you, not a sales pitch for one.
Dysport: Spreads Wider, Often Visible a Day or Two Sooner
Dysport is AbobotulinumtoxinA. Its molecule diffuses slightly more than Botox's, which makes it a common choice for broader areas like the forehead where an even spread is an advantage. Patients frequently notice softening at 2–3 days, versus 3–5 days for Botox — a small but real difference for anyone counting down to an event.
Dosing isn't interchangeable: Dysport uses roughly 2.5–3 units for every 1 unit of Botox, so a 'unit count' only means something within the same product. Full effect and duration land in the same range as Botox — 10–14 days to peak, 3–4 months of effect.
Xeomin: The Toxin Without the Extra Proteins
Xeomin is IncobotulinumtoxinA, nicknamed the 'naked' toxin because it's manufactured without the accessory complexing proteins that Botox and Dysport carry — only the active molecule is present. In theory that lowers the already-low chance of the body forming resistance over years of repeated treatment, though most patients simply choose it because it dosed close to 1:1 with Botox and performs almost identically in practice.
Onset, peak and duration track Botox closely: visible around 3–5 days, full effect at 10–14 days, lasting 3–4 months.
Where Jeuveau Fits — and Why We Don't Currently Carry It
Jeuveau (PrabotulinumtoxinA, sometimes marketed as 'Newtox') is a fourth FDA-approved option, formulated and marketed specifically for cosmetic use rather than adapted from a medical toxin. Independent studies haven't shown a clinically meaningful difference in onset, duration or effect compared to Botox, Dysport or Xeomin — the choice mostly comes down to what a clinic stocks and prices.
We keep our neuromodulator range to Botox, Dysport, Xeomin and Letybo so dosing stays consistent across your visits and we can speak from direct, repeated experience with each. If Jeuveau is specifically what you're after, say so at consultation — we'll give you an honest answer rather than substitute something else and call it the same thing.
How We Help You Choose
In practice, the decision usually comes down to three things: how you've responded to a product before, how soon you need to see a result, and which area is being treated. Someone with an event in four days leans toward Dysport's faster onset. Someone who has developed a mild resistance to Botox after years of use might do better on Xeomin's purified formulation. Most first-time patients simply start with Botox, because it's the best-documented of the group and gives us a clean baseline to compare future visits against.
None of that is decided over the phone. Assessing how your specific muscles move is what determines both the product and the dose — the same reason two people with an identical wrinkle rarely get the same treatment plan.
